Text Size
818 studies found for:    glioblastoma

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
glioblastoma (818 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Evaluation of [18F]-FMISO for Non Operated Glioblastoma
Condition: Glioblastoma
Intervention: Procedure: 18F]-FMISO PET-CT
2 Active, not recruiting Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Avastin;   Drug: Tarceva;   Drug: Temodar
3 Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
4 Recruiting A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: PD 0332991
5 Recruiting Amgen 386 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Amgen 386;   Drug: Bevacizumab
6 Recruiting Biomarkers for Prognosis of Glioblastoma (GBM)
Condition: Glioblastoma
Intervention:
7 Recruiting A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component;   Recurrent Glioblastoma;   Relapsed Glioblastoma
Interventions: Drug: Bevacizumab;   Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: KLH
8 Recruiting A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: onartuzumab;   Drug: bevacizumab;   Drug: onartuzumab placebo;   Drug: bevacizumab placebo
9 Recruiting Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma
Interventions: Biological: bevacizumab;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: microarray analysis;   Genetic: DNA methylation analysis
10 Completed
Has Results 		6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Conditions: Anaplastic Glioma of Brain;   Glioblastoma Multiforme;   Brain Cancer
Interventions: Drug: Capecitabine;   Drug: Celecoxib (Celebrex);   Drug: Temozolomide;   Drug: Lomustine;   Drug: 6-Thioguanine
11 Not yet recruiting A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Drug: TMZ plus concurrent re-irradiation;   Drug: Temozolomide
12 Suspended Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Condition: Glioblastoma
Intervention: Drug: nelfinavir
13 Active, not recruiting Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: glioblastoma multiforme multipeptide vaccine IMA950;   Biological: sargramostim;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: adjuvant therapy;   Radiation: radiation therapy
14 Withdrawn Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
Condition: Glioblastoma Multiforme
Intervention: Drug: IL-4PE
15 Completed Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma;   Gliosarcoma;   Malignant Gliomas
Interventions: Drug: lenalidomide;   Radiation: Radiation
16 Unknown † A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
Condition: Glioblastoma
Intervention: Procedure: FDG-PET
17 Unknown † Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
Condition: Glioblastoma
Intervention: Drug: Temozolomide
18 Completed PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Condition: Glioblastoma
Interventions: Drug: PTK787/ZK 222584;   Drug: Temozolomide;   Procedure: Radiation Therapy
19 Active, not recruiting A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
20 Recruiting A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Intervention: Drug: Intrathecal liposomal Ara-C + Temozolomide
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years